{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:34:58Z","timestamp":1793090098297,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105618","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:28:35Z","timestamp":1790098115000},"page":"105618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bridging the translational gap in osteosarcoma T-cell therapy: A narrative critical review of preclinical models"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-2938","authenticated-orcid":false,"given":"Zhi","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.critrevonc.2026.105618_bib1","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2014.58.0225","article-title":"Human epidermal growth factor receptor 2 (HER2) -specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma","volume":"33","author":"Ahmed","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2541974","article-title":"Establishing a pediatric solid tumor PDX biobank for precision oncology research","volume":"26","author":"Akemi Kido","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105618_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100521","article-title":"Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma","volume":"44","author":"An","year":"2024","journal-title":"J. Bone Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ccell.2023.11.012","article-title":"T cells in patients with osteosarcoma and neuroblastoma-it's not only the T cells that matter","volume":"42","author":"Arnett","year":"2024","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105618_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008608","article-title":"Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis","volume":"12","author":"Ash","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105618_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/03009858221083038","article-title":"Canine and murine models of osteosarcoma","volume":"59","author":"Beck","year":"2022","journal-title":"Vet. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105618_bib7","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1158\/0008-5472.CAN-18-3340","article-title":"Positron emission tomography detects in vivo expression of disialoganglioside GD2 in mouse models of primary and metastatic osteosarcoma","volume":"79","author":"Butch","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105618_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00262-024-03642-4","article-title":"Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity","volume":"73","author":"Cao","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"176","key":"10.1016\/j.critrevonc.2026.105618_bib9","doi-asserted-by":"crossref","DOI":"10.3791\/63072","article-title":"Intratibial osteosarcoma cell injection to generate orthotopic osteosarcoma and lung metastasis mouse models","author":"Chang","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.critrevonc.2026.105618_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","article-title":"Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs","volume":"500","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105618_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41587-022-01650-2","article-title":"Synapse-tuned CARs enhance immune cell anti-tumor activity","volume":"41","author":"Chockley","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105618_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/2767-9764.CRC-25-0086","article-title":"Preclinical evaluation of folate receptor-\u03b1 chimeric antigen receptor T cells exhibits highly efficient antitumor activity against osteosarcoma","volume":"5","author":"Choe","year":"2025","journal-title":"Cancer Res. Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105618_bib13","first-page":"674","article-title":"GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas","volume":"10","author":"Chulanetra","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"53","key":"10.1016\/j.critrevonc.2026.105618_bib14","doi-asserted-by":"crossref","first-page":"30163","DOI":"10.18632\/oncotarget.25733","article-title":"Disulfiram reduces metastatic osteosarcoma tumor burden in an immunocompetent Balb\/c or-thotopic mouse model","volume":"9","author":"Crasto","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13046-020-01685-w","article-title":"The role of extracelluar matrix in osteosarcoma progression and metastasis","volume":"39","author":"Cui","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1166063","article-title":"Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models","volume":"13","author":"da Costa","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105618_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00432-006-0157-x","article-title":"Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing","volume":"133","author":"Dass","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105618_bib18","article-title":"Vitro Strategies to Vascularize 3D Physiologically Relevant Models","volume":"8","author":"Dellaquila","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.critrevonc.2026.105618_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107867","article-title":"RAE1-armoured DC vaccine boosts NKG2D-CAR-T cells elicited anti-solid tumour treatment","volume":"219","author":"Duan","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fonc.2020.00013","article-title":"Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression","volume":"10","author":"Fan","year":"2020","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105618_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.32604\/or.2024.054207","article-title":"Research progress on cancer-associated fibroblasts in osteosarcoma","volume":"33","author":"Feng","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib22","article-title":"The roles of glycolysis in osteosarcoma","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105618_bib23","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1158\/1078-0432.CCR-17-0075","article-title":"Memory T cells expressing an NKG2D-CAR efficiently target osteosarcoma cells","volume":"23","author":"Fern\u00e1ndez","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actbio.2018.05.034","article-title":"Design of spherically structured 3D in vitro tumor models -Advances and prospects","volume":"75","author":"Ferreira","year":"2018","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105618_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11999.0000000000000003","article-title":"Quantitative Primary Tumor Indocyanine Green Measurements Predict Osteosarcoma Metastatic Lung Burden in a Mouse Model","volume":"476","author":"Fourman","year":"2018","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"749","key":"10.1016\/j.critrevonc.2026.105618_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg9814","article-title":"Payload-delivering engineered \u03b3\u03b4 T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma","volume":"16","author":"Fowler","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105618_bib27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","article-title":"CSF1\/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105618_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1384795","article-title":"Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature","volume":"11","author":"Gamie","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105618_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-43032-0_5","article-title":"HER2-Targeted Therapy in Osteosarcoma","volume":"1257","author":"Gill","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105618_bib30","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.18632\/aging.204567","article-title":"A novel circular RNA circRBMS3 regulates proliferation and metastasis of osteosarcoma by targeting miR-424-eIF4B\/YRDC axis","volume":"15","author":"Gong","year":"2023","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105618_bib31","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1097\/JS9.0000000000003988","article-title":"Chimeric antigen receptor T-cell therapy in patients with lymphoma: a machine learning-driven decadal informatics network analysis","volume":"112","author":"Guo","year":"2026","journal-title":"Int. J. Surg."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105618_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012591","article-title":"Etoposide activates CD8(+) T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling","volume":"13","author":"He","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105618_bib33","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ymthe.2017.05.012","article-title":"CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma","volume":"25","author":"Heczey","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib34","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1038\/s41467-020-17175-8","article-title":"Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma","volume":"11","author":"Hegde","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105618_bib35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s43018-024-00749-6","article-title":"Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial","volume":"5","author":"Hegde","year":"2024","journal-title":"Nat. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105618_bib36","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/ijc.33382","article-title":"Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma","volume":"148","author":"Hennessy","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105618_bib37","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00262-023-03437-z","article-title":"Switchable CAR T cell strategy against osteosarcoma","volume":"72","author":"Hidalgo","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105618_bib38","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.21873\/anticanres.15406","article-title":"Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review","volume":"41","author":"Higuchi","year":"2021","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.957844","article-title":"Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application","volume":"12","author":"Higuchi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105618_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.addr.2014.05.003","article-title":"\"In vitro\" 3D models of tumor-immune system interaction","volume":"79-80","author":"Hirt","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006991","article-title":"Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models","volume":"12","author":"Hu","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003633","article-title":"Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors","volume":"10","author":"Hu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105618_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1462076","article-title":"A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma","volume":"15","author":"Hui","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105618_bib44","doi-asserted-by":"crossref","first-page":"10327","DOI":"10.1021\/acsnano.2c00192","article-title":"Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy","volume":"16","author":"Jin","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105618_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105461","article-title":"Monolayer (2D) or spheroids (3D) cell cultures for nanotoxicological studies? Comparison of cytotoxicity and cell internalization of nanoparticles","volume":"85","author":"Juarez-Moreno","year":"2022","journal-title":"Toxicol. Vitr."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12967-020-02348-2","article-title":"Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma","volume":"18","author":"Kallis","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105618_bib48","article-title":"vivo imaging of nanoparticle-labeled CAR T cells","volume":"119","author":"Kiru","year":"2022"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105618_bib49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11626-018-0274-2","article-title":"Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line","volume":"54","author":"Kito","year":"2018","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"issue":"26","key":"10.1016\/j.critrevonc.2026.105618_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300903","article-title":"Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro Models","volume":"12","author":"Landon-Brace","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105618_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020416","article-title":"Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma","volume":"10","author":"Landuzzi","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105618_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-024-03022-x","article-title":"A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKC\u03b1 activation","volume":"43","author":"Lee","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib54","first-page":"364","article-title":"Overall review of curative impact and barriers of CAR-T cells in osteosarcoma","volume":"23","author":"Li","year":"2024","journal-title":"Excli J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13046-021-02146-8","article-title":"ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K\/AKT pathway","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1290762","article-title":"Current status and future challenges of CAR-T cell therapy for osteosarcoma","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105618_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119607","article-title":"Astragalus injection inhibits the growth of osteosarcoma by activating cytotoxic T lymphocyte and targeting CTSL","volume":"345","author":"Liu","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105618_bib58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/CJI.0000000000000065","article-title":"Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1\/PD-L1 interactions","volume":"38","author":"Lussier","year":"2015","journal-title":"J. Immunother."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105618_bib59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41401-020-0376-8","article-title":"PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine osteosarcoma cells","volume":"41","author":"Lv","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105618_bib60","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1535-7163.MCT-19-0903","article-title":"Gefitinib Inhibits Invasion and Metastasis of Osteosarcoma via Inhibition of Macrophage Receptor Interacting Serine-Threonine Kinase 2","volume":"19","author":"Maloney","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s42003-025-07992-2","article-title":"The tumor microenvironment of metastatic osteosarcoma in the human and canine lung","volume":"8","author":"McGee","year":"2025","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105618_bib62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/ijc.30572","article-title":"Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models","volume":"140","author":"Meier","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12929-024-01049-y","article-title":"Osteosarcoma in a ceRNET perspective","volume":"31","author":"Mosca","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-023-02653-w","article-title":"Newly developed 3D in vitro models to study tumor-immune interaction","volume":"42","author":"Mu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48634-y","article-title":"Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations","volume":"9","author":"Nanni","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105618_bib66","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1158\/1078-0432.CCR-24-0246","article-title":"Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition","volume":"30","author":"Panagi","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13045-020-01012-y","article-title":"GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma","volume":"13","author":"Park","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105618_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006680","article-title":"Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody","volume":"11","author":"Park","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13045-024-01641-7","article-title":"Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells","volume":"17","author":"Pezzella","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105618_bib70","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/1078-0432.CCR-21-2105","article-title":"Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma","volume":"28","author":"Regan","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105618_bib71","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1158\/0008-5472.CAN-24-3360","article-title":"Metastasis-Initiating Osteosarcoma Subpopulations Establish Paracrine Interactions with Lung and Tumor Cells to Create a Metastatic Niche","volume":"85","author":"Reinecke","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00018-025-06013-z","article-title":"Choosing the right animal model for sarcoma research","volume":"83","author":"Remiszewski","year":"2026","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-016-0392-1","article-title":"Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model","volume":"35","author":"Robl","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-319-04843-7_13","article-title":"Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?","volume":"804","author":"Rodriguez","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.critrevonc.2026.105618_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1141666","article-title":"Editorial: Canine osteosarcoma as a model in comparative oncology: Advances and perspective","volume":"10","author":"Romanucci","year":"2023","journal-title":"Front. Vet. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105618_bib76","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molmed.2011.02.004","article-title":"Dog models of naturally occurring cancer","volume":"17","author":"Rowell","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105618_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.826113","article-title":"Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research","volume":"12","author":"Salinas-Vera","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105618_bib78","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/17460441.2013.817988","article-title":"Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery","volume":"8","author":"Sampson","year":"2013","journal-title":"Expert. Opin. Drug. Discov."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105618_bib79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1158\/1078-0432.CCR-23-0873","article-title":"Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach","volume":"30","author":"Schott","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib80","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1186\/s12885-019-6103-5","article-title":"Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice","volume":"19","author":"Shekhar","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105618_bib81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/bph.70188","article-title":"Comparative metabolomic and transcriptomic analysis of 2D and 3D mesenchymal stem cell cultures for improved therapeutic applications","volume":"183","author":"Shrestha","year":"2026","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105618_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1657760","article-title":"Central memory-enriched V\u03b39V\u03b42 \u03b3\u03b4 T cells via TGF-\u03b2 expansion demonstrate enhanced in vivo efficacy against metastatic osteosarcoma","volume":"16","author":"Silva","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105618_bib83","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcyt.2016.04.003","article-title":"Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells","volume":"18","author":"Stroncek","year":"2016","journal-title":"Cytotherapy"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105618_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400864","article-title":"Biomaterials-Boosted Immunotherapy for Osteosarcoma","volume":"13","author":"Sun","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"205","key":"10.1016\/j.critrevonc.2026.105618_bib85","doi-asserted-by":"crossref","DOI":"10.3791\/66491","article-title":"Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues","author":"Sun","year":"2024","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.critrevonc.2026.105618_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691741","article-title":"A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells","volume":"12","author":"Talbot","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105618_bib87","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1158\/1078-0432.CCR-23-3298","article-title":"Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models","volume":"30","author":"Talbot","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156291","article-title":"Decoding the role of SLC25A5 in osteosarcoma drug resistance and CD8+ T cell exhaustion: The therapeutic potential of phyllanthin","volume":"136","author":"Tang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.critrevonc.2026.105618_bib89","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fimmu.2018.00377","article-title":"Valproic Acid Combined with Zoledronate Enhance \u03b3\u03b4 T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib90","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-019-1147-6","article-title":"Anti-CD166\/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105618_bib91","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3389\/fimmu.2018.01239","article-title":"Decitabine Enhances V\u03b39V\u03b42 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL-NKG2D Axis","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105618_bib92","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41416-022-02100-1","article-title":"Development of CAR-T cells specifically targeting cancer stem cell antigen DNAJB8 against solid tumours","volume":"128","author":"Watanabe","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib93","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12935-021-01943-7","article-title":"Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma","volume":"21","author":"Weinman","year":"2021","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.critrevonc.2026.105618_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215887","article-title":"Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential","volume":"547","author":"Wen","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105618_bib96","first-page":"159","article-title":"Comparative aspects of osteosarcoma","volume":"270","author":"Withrow","year":"1991","journal-title":"Dog Versus Man. Clin. Orthop. Relat. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105618_bib97","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41419-018-0647-1","article-title":"Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma","volume":"9","author":"Yao","year":"2018","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105618_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100660","article-title":"Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets","volume":"51","author":"Yin","year":"2025","journal-title":"J. Bone Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13578-021-00600-w","article-title":"Research models and mesenchymal\/epithelial plasticity of osteosarcoma","volume":"11","author":"Yu","year":"2021","journal-title":"Cell. Biosci."},{"issue":"Pt B","key":"10.1016\/j.critrevonc.2026.105618_bib101","article-title":"Pluripotent stem cell-derived CTLs targeting FGFR3-TACC3 fusion gene in osteosarcoma","volume":"142","author":"Zhan","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105618_bib102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11914-019-00521-1","article-title":"Studies on Osteocytes in Their 3D Native Matrix Versus 2D In Vitro Models","volume":"17","author":"Zhang","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.critrevonc.2026.105618_bib103","article-title":"Advances in T cell-based immunotherapy for osteosarcoma","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105618_bib104","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1186\/s12885-022-10229-8","article-title":"B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105618_bib105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/1535-7163.MCT-21-0726","article-title":"B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105618_bib106","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.7150\/thno.51245","article-title":"H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105618_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/jfb16060213","article-title":"Material-Driven Therapeutics: Functional Nanomaterial Design Paradigms Revolutionizing Osteosarcoma Treatment","volume":"16","author":"Zhang","year":"2025","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.critrevonc.2026.105618_bib108","article-title":"Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:46:19Z","timestamp":1793087179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":108,"alternative-id":["S1040842826005056"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105618","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the translational gap in osteosarcoma T-cell therapy: A narrative critical review of preclinical models","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105618"}}